文献速递产科母胎医学生殖医学

从晚育父亲到单基因病产前筛查:证据与伦理关切

From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
PubMed 文献 · Hum Reprod Update · 2021-01-01

该综述基于1980-2021年PubMed与Google Scholar文献,探讨晚育父亲对单基因病起源的影响及无创产前检测(NIPT)的作用。晚育父亲导致新发突变累积,可引发父源年龄效应疾病;多病种单基因病NIPT(MD-NIPT)敏感性及特异性近100%,但需权衡伦理挑战。

要点

  • 晚育父亲通过累积新发突变增加父源年龄效应单基因病风险。
  • MD-NIPT对父源年龄效应单基因病筛查敏感性及特异性近100%。
  • MD-NIPT应用需平衡生殖自主权、知情同意等伦理问题。

核心结论

  • 晚育父亲导致新发突变累积,增加父源年龄效应单基因病风险,MD-NIPT可提供安全筛查但需评估伦理挑战。

研究设计与样本

  • 综述,检索PubMed和Google Scholar数据库1980-2021年英文同行评议文献。

主要发现

  • 晚育父亲引起连续分裂的生殖细胞中新发突变累积。
  • 部分新发突变通过影响RAS-MAPK信号通路对精原细胞有利,导致自私精原细胞选择和扩增。
  • 在子代中,这些自私新发突变导致严重甚至危及生命的父源年龄效应疾病。
  • MD-NIPT对多种父源年龄效应单基因病筛查的敏感性和特异性接近100%。

关键数值与推荐

  • MD-NIPT可筛查有父源年龄效应疾病和单基因病风险的妊娠,这些妊娠占所有妊娠的20%。
  • 主要风险妊娠包括父亲年龄超过40岁、既往有受累妊娠/孩子史和/或常规超声发现先天畸形。
  • MD-NIPT敏感性和特异性接近100%。

临床怎么用

  • 对父亲年龄超过40岁、既往有受累妊娠/孩子史或超声发现先天畸形的妊娠,可考虑MD-NIPT筛查。
  • 引入MD-NIPT需平衡生殖自主权、知情同意、残疾歧视、父亲权利、公平正义和咨询等伦理问题。

局限性

  • 综述未报告原始研究的具体样本量、置信区间和P值等数值。
  • MD-NIPT的临床实施需进一步评估伦理挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the help of ART, an advanced parental age is not considered to be a serious obstacle for reproduction anymore. However, significant health risks for future offspring hide behind the success of reproductive medicine for the treatment of reduced fertility associated with late parenthood. Although an advanced maternal age is a well-known risk factor for poor reproductive outcomes, understanding the impact of an advanced paternal age on offspring is yet to be elucidated. De novo monogenic disorders (MDs) are highly associated with late fatherhood. MDs are one of the major sources of paediatric morbidity and mortality, causing significant socioeconomic and psychological burdens to society. Although individually rare, the combined prevalence of these disorders is as high as that of chromosomal aneuploidies, indicating the increasing need for prenatal screening. With the help of advanced reproductive technologies, families with late paternity have the option of non-invasive prenatal testing (NIPT) for multiple MDs (MD-NIPT), which has a sensitivity and specificity of almost 100%. OBJECTIVE AND RATIONALE: The main aims of the current review were to examine the effect of late paternity on the origin and nature of MDs, to highlight the role of NIPT for the detection of a variety of paternal age-associated MDs, to describe clinical experiences and to reflect on the ethical concerns surrounding the topic of late paternity and MD-NIPT. SEARCH METHODS: An extensive search of peer-reviewed publications (1980-2021) in English from the PubMed and Google Scholar databases was based on key words in different combinations: late paternity, paternal age, spermatogenesis, selfish spermatogonial selection, paternal age effect, de novo mutations (DNMs), MDs, NIPT, ethics of late fatherhood, prenatal testing and paternal rights. OUTCOMES: An advanced paternal age provokes the accumulation of DNMs, which arise in continuously dividing germline cells. A subset of DNMs, owing to their effect on the rat sarcoma virus protein-mitogen-activated protein kinase signalling pathway, becomes beneficial for spermatogonia, causing selfish spermatogonial selection and outgrowth, and in some rare cases may lead to spermatocytic seminoma later in life. In the offspring, these selfish DNMs cause paternal age effect (PAE) disorders with a severe and even life-threatening phenotype. The increasing tendency for late paternity and the subsequent high risk of PAE disorders indicate an increased need for a safe and reliable detection procedure, such as MD-NIPT. The MD-NIPT approach has the capacity to provide safe screening for pregnancies at risk of PAE disorders and MDs, which constitute up to 20% of all pregnancies. The primary risks include pregnancies with a paternal age over 40 years, a previous history of an affected pregnancy/child, and/or congenital anomalies detected by routine ultrasonography. The implementation of NIPT-based screening would support the early diagnosis and management needed in cases of affected pregnancy. However, the benefits of MD-NIPT need to be balanced with the ethical challenges associated with the introduction of such an approach into routine clinical practice, namely concerns regarding reproductive autonomy, informed consent, potential disability discrimination, paternal rights and PAE-associated issues, equity and justice in accessing services, and counselling. WIDER IMPLICATIONS: Considering the increasing parental age and risks of MDs, combined NIPT for chromosomal aneuploidies and microdeletion syndromes as well as tests for MDs might become a part of routine pregnancy management in the near future. Moreover, the ethical challenges associated with the introduction of MD-NIPT into routine clinical practice need to be carefully evaluated. Furthermore, more focus and attention should be directed towards the ethics of late paternity, paternal rights and paternal genetic guilt associated with pregnancies affected with PAE MDs.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Zhytnik L, Peters M, Tilk K, et al. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns. Hum Reprod Update. 2021. PMID: 34329448. doi:10.1093/humupd/dmab023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。